APA

Davoren J. E., Lee C., Garnsey M., Brodney M. A., Cordes J., Dlugolenski K., Edgerton J. R., Harris A. R., Helal C. J., Jenkinson S., Kauffman G. W., Kenakin T. P., Lazzaro J. T., Lotarski S. M., Mao Y., Nason D. M., Northcott C., Nottebaum L., O'Neil S. V., Pettersen B., Popiolek M., Reinhart V., Salomon-Ferrer R., Steyn S. J., Webb D., Zhang L. & Grimwood S. (20170529). Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. : Journal of medicinal chemistry.

Chicago

Davoren Jennifer E, Lee Che-Wah, Garnsey Michelle, Brodney Michael A, Cordes Jason, Dlugolenski Keith, Edgerton Jeremy R, Harris Anthony R, Helal Christopher J, Jenkinson Stephen, Kauffman Gregory W, Kenakin Terrence P, Lazzaro John T, Lotarski Susan M, Mao Yuxia, Nason Deane M, Northcott Carrie, Nottebaum Lisa, O'Neil Steven V, Pettersen Betty, Popiolek Michael, Reinhart Veronica, Salomon-Ferrer Romelia, Steyn Stefanus J, Webb Damien, Zhang Lei and Grimwood Sarah. 20170529. Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. : Journal of medicinal chemistry.

Harvard

Davoren J. E., Lee C., Garnsey M., Brodney M. A., Cordes J., Dlugolenski K., Edgerton J. R., Harris A. R., Helal C. J., Jenkinson S., Kauffman G. W., Kenakin T. P., Lazzaro J. T., Lotarski S. M., Mao Y., Nason D. M., Northcott C., Nottebaum L., O'Neil S. V., Pettersen B., Popiolek M., Reinhart V., Salomon-Ferrer R., Steyn S. J., Webb D., Zhang L. and Grimwood S. (20170529). Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. : Journal of medicinal chemistry.

MLA

Davoren Jennifer E, Lee Che-Wah, Garnsey Michelle, Brodney Michael A, Cordes Jason, Dlugolenski Keith, Edgerton Jeremy R, Harris Anthony R, Helal Christopher J, Jenkinson Stephen, Kauffman Gregory W, Kenakin Terrence P, Lazzaro John T, Lotarski Susan M, Mao Yuxia, Nason Deane M, Northcott Carrie, Nottebaum Lisa, O'Neil Steven V, Pettersen Betty, Popiolek Michael, Reinhart Veronica, Salomon-Ferrer Romelia, Steyn Stefanus J, Webb Damien, Zhang Lei and Grimwood Sarah. Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects. : Journal of medicinal chemistry. 20170529.